二甲双胍通过调控成骨与破骨细胞分化减少根尖周炎骨吸收
本研究在体外低氧培养的MC3T3-E1前成骨细胞和RAW264.7巨噬细胞及10只Sprague-Dawley大鼠根尖周炎模型中,评估二甲双胍对成骨分化和破骨形成的影响。结果显示二甲双胍可逆转低氧对RUNX2的抑制、减少RANKL和TRAP合成,根管内给药减轻大鼠根尖周骨丧失。
要点
- 二甲双胍可逆转低氧抑制的成骨细胞RUNX2表达并减少RANKL合成。
- 二甲双胍抑制低氧和RANKL增强的巨噬细胞TRAP生成。
- 根管内二甲双胍可减轻大鼠根尖周炎骨丧失并增强RUNX2表达。
核心结论
- 根管内二甲双胍减轻大鼠根尖周炎骨吸收,与增强成骨细胞分化和减少破骨细胞形成相关。
- 结果支持二甲双胍作为炎症性骨病的有效药物。
研究设计与样本
- 体外培养小鼠前成骨细胞MC3T3-E1和巨噬细胞RAW264.7,在2%低氧或21%常氧下培养并按需给予RANKL刺激。
- 在10只Sprague-Dawley大鼠下颌第一磨牙诱导根尖周炎,进行伴或不伴二甲双胍补充的根管治疗。
主要发现
- 低氧抑制前成骨细胞RUNX2表达并增强RANKL合成。
- 低氧和/或RANKL刺激后巨噬细胞TRAP生成增加。
- 二甲双胍逆转低氧诱导的前成骨细胞RUNX2抑制和RANKL合成。
- 二甲双胍抑制低氧和RANKL增强的巨噬细胞TRAP合成。
- 根管内二甲双胍减少大鼠根尖周炎骨丧失,与对照相比骨表面衬里细胞RUNX2表达显著增强、RANKL和TRAP合成减少。
临床怎么用
- 根管内应用二甲双胍可能作为辅助措施减轻根尖周炎相关骨吸收。
- 临床决策需结合患者全身情况评估二甲双胍局部使用的适用性。
局限性
- 研究仅使用10只大鼠的动物模型及体外细胞实验,样本量有限。
- 二甲双胍局部应用的最佳剂量、给药频率及长期安全性未在原文中报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: We have previously demonstrated that auxiliary metformin therapy promotes healing of apical periodontitis. Here we aimed to investigate the effects of metformin on osteoblast differentiation and osteoclast formation in cultured cells and rat apical periodontitis. METHODS: Murine pre-osteoblasts MC3T3-E1 and macrophages RAW264.7 were cultured under hypoxia (2% oxygen) or normoxia (21% oxygen) and stimulated with receptor activator of nuclear factor-κB ligand (RANKL) when indicated. Metformin was added to the cultures to evaluate its anti-hypoxic effects. Expressions of osteoblast differentiation regulator runt-related transcription factor 2 (RUNX2), RANKL, and osteoclast marker tartrate-resistant acid phosphatase (TRAP) were assessed by Western blot. Apical periodontitis was induced in mandibular first molars of 10 Sprague-Dawley rats. Root canal therapy with or without metformin supplement was performed. Periapical bone resorption was measured by micro-computed tomography. Immunohistochemistry was used to examine RUNX2, RANKL, and TRAP expressions. RESULTS: Hypoxia suppressed RUNX2 expression and enhanced RANKL synthesis in pre-osteoblasts. TRAP production increased in macrophages after hypoxia and/or RANKL stimulation. Metformin reversed hypoxia-induced RUNX2 suppression and RANKL synthesis in pre-osteoblasts. Metformin also inhibited hypoxia and RANKL-enhanced TRAP synthesis in macrophages. Intracanal metformin diminished bone loss in rat apical periodontitis. Comparing with vehicle control, cells lining bone surfaces in metformin-treated lesions had significantly stronger expression of RUNX2 and decreased synthesis of RANKL and TRAP. CONCLUSIONS: Alleviation of bone resorption by intracanal metformin was associated with enhanced osteoblast differentiation and diminished osteoclast formation in rat apical periodontitis. Our results endorsed the role of metformin as an effective medicament for inflammatory bone diseases.
引用
- Hong CY, Lin SK, Wang HW, et al. Metformin Reduces Bone Resorption in Apical Periodontitis Through Regulation of Osteoblast and Osteoclast Differentiation. J Endod. 2023. PMID: 37454872. doi:10.1016/j.joen.2023.07.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。